Cinzia Scandellari

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Sars-CoV2 infection in pregnant women with multiple sclerosis.

Sars-CoV2 infection in pregnant women with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 26, 2023

The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study.

The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study.

Journal: Multiple sclerosis and related disorders
Published: July 28, 2022

Signs and symptoms of COVID-19 in patients with multiple sclerosis.

Signs and symptoms of COVID-19 in patients with multiple sclerosis.

Journal: European journal of neurology
Published: April 04, 2022

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.

Journal: Multiple sclerosis and related disorders
Published: February 22, 2022

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.

Journal: European journal of neurology
Published: October 20, 2021

Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.

Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.

Journal: Frontiers in neurology
Published: September 28, 2021

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 15, 2021

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results.

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 27, 2020

Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship.

Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship.

Journal: Clinical neuropharmacology
Published: July 20, 2018

Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis.

Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 19, 2018

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 25, 2018

Teeth loss after teriflunomide treatment: Casual or causal? A short case series.

Teeth loss after teriflunomide treatment: Casual or causal? A short case series.

Journal: Multiple sclerosis and related disorders
Published: December 28, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026